TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
01 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
02 3CDYMAX (INDIA) PHARMA PRIVATE LIMITED Bangalore IN
03 1CIPLA LIMITED Mumbai IN
04 1DEVA HOLDING A.Ş. Istanbul TR
05 1F.I.S. - Fabbrica Italiana Sintetici S.p.A. Montecchio Maggiore IT
06 3HETERO LABS LIMITED Hyderabad IN
07 1INTAS PHARMACEUTICALS LIMITED Ahmedabad IN
08 2LAURUS LABS LIMITED Hyderabad IN
09 1MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN
10 1NATCO PHARMA LIMITED Hyderabad IN
11 1SHANDONG ANXIN PHARMACEUTICAL CO., LTD Dongjia Town CN
12 1SHANDONG ANXIN PHARMACEUTICAL CO., LTD. Dongjia Town CN
13 1SHILPA PHARMA LIFESCIENCES LIMITED Raichur IN
14 1SIGNA S.A. DE C.V. Toluca MX
15 1SYNTHIMED LABS PRIVATE LIMITED Derabassi IN
16 1Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City CN
01 10Imatinib mesilate
02 1Imatinib mesilate, Alpha form
03 1Imatinib mesilate, Form α
04 1Imatinib mesilate, Form α, Process II
05 2Imatinib mesilate, Form-α
06 1Imatinib mesilate, Form-β
07 1Imatinib mesilate, Process 2
08 1Imatinib mesilate, Process II
09 1Imatinib mesilate, α Form
10 1Imatinib mesilate, β form, milled, non-milled
11 1Imatinib mesilate, β-form
01 3China
02 14India
03 1Israel
04 1Italy
05 1Mexico
06 1Turkey
01 1Expired
02 20Valid
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : R1-CEP 2015-096 - Rev 03
Status : Valid
Issue Date : 2023-07-19
Type : Chemical
Substance Number : 2736
Certificate Number : R0-CEP 2018-262 - Rev 01
Status : Valid
Issue Date : 2022-10-24
Type : Chemical
Substance Number : 2736
Certificate Number : CEP 2023-069 - Rev 00
Status : Valid
Issue Date : 2024-10-14
Type : Chemical
Substance Number : 2736
Certificate Number : R1-CEP 2016-058 - Rev 00
Status : Valid
Issue Date : 2022-08-04
Type : Chemical
Substance Number : 2736
Certificate Number : R1-CEP 2016-275 - Rev 00
Status : Valid
Issue Date : 2023-06-09
Type : Chemical
Substance Number : 2736
Certificate Number : CEP 2018-047 - Rev 02
Status : Valid
Issue Date : 2024-11-15
Type : Chemical
Substance Number : 2736
Certificate Number : R1-CEP 2015-245 - Rev 01
Status : Valid
Issue Date : 2023-01-18
Type : Chemical
Substance Number : 2736
Certificate Number : CEP 2017-118 - Rev 01
Status : Valid
Issue Date : 2024-03-15
Type : Chemical
Substance Number : 2736
Imatinib Mesilate, β Form, Milled, Non-milled
Certificate Number : CEP 2017-292 - Rev 03
Status : Valid
Issue Date : 2024-06-28
Type : Chemical
Substance Number : 2736
Certificate Number : R1-CEP 2016-121 - Rev 01
Status : Valid
Issue Date : 2022-07-20
Type : Chemical
Substance Number : 2736
A Imatinib Mesilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imatinib Mesilate, including repackagers and relabelers. The FDA regulates Imatinib Mesilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imatinib Mesilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imatinib Mesilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imatinib Mesilate supplier is an individual or a company that provides Imatinib Mesilate active pharmaceutical ingredient (API) or Imatinib Mesilate finished formulations upon request. The Imatinib Mesilate suppliers may include Imatinib Mesilate API manufacturers, exporters, distributors and traders.
click here to find a list of Imatinib Mesilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imatinib Mesilate CEP of the European Pharmacopoeia monograph is often referred to as a Imatinib Mesilate Certificate of Suitability (COS). The purpose of a Imatinib Mesilate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Imatinib Mesilate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Imatinib Mesilate to their clients by showing that a Imatinib Mesilate CEP has been issued for it. The manufacturer submits a Imatinib Mesilate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Imatinib Mesilate CEP holder for the record. Additionally, the data presented in the Imatinib Mesilate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Imatinib Mesilate DMF.
A Imatinib Mesilate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Imatinib Mesilate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Imatinib Mesilate suppliers with CEP (COS) on PharmaCompass.
We have 15 companies offering Imatinib Mesilate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
